Correlation Between Sarepta Therapeutics and Surrozen Warrant

Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Surrozen Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Surrozen Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarepta Therapeutics and Surrozen Warrant, you can compare the effects of market volatilities on Sarepta Therapeutics and Surrozen Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Surrozen Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Surrozen Warrant.

Diversification Opportunities for Sarepta Therapeutics and Surrozen Warrant

-0.48

Correlation Coefficient

Sarepta Therapeutics  Surrozen Warrant

Very good diversification

The 3 months correlation between Sarepta and Surrozen is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Surrozen Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen Warrant and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Surrozen Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen Warrant has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Surrozen Warrant go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and Surrozen Warrant

Given the investment horizon of 90 days Sarepta Therapeutics is expected to under-perform the Surrozen Warrant. But the stock apears to be less risky and, when comparing its historical volatility, Sarepta Therapeutics is 19.38 times less risky than Surrozen Warrant. The stock trades about -0.18 of its potential returns per unit of risk. The Surrozen Warrant is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  2.45  in Surrozen Warrant on December 4, 2024 and sell it today you would earn a total of  0.61  from holding Surrozen Warrant or generate 24.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	71.19%
Values	Daily Returns

Sarepta Therapeutics  vs.  Surrozen Warrant

Sarepta Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Surrozen Warrant

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen Warrant are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Surrozen Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sarepta Therapeutics and Surrozen Warrant

The main advantage of trading using opposite Sarepta Therapeutics and Surrozen Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Surrozen Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen Warrant will offset losses from the drop in Surrozen Warrant's long position.

The idea behind Sarepta Therapeutics and Surrozen Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.